Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms(395 views) Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, Donato V, Orecchia R, Salvatore M, Pacelli R
Institute of Biostructures and Bioimaging, National Council of Research (CNR), Napoli, Italy
Department of Diagnostic Imaging and Radiation Oncology, University Federico II of Napoli, Napoli, Italy
Department of Health Physics, S. Camillo-Forlanini Hospital, Roma, Italy
Unit of Medical Physics, Centro Nazionale di Adroterapia Oncologica Foundation, Pavia, Italy
Vetsussie Faculty, University of Zürich and Radiotherapy, Hirslanden, Aarau, Switzerland
Department of Radiation Oncology, S. Camillo-Forlanini Hospital, Roma, Italy
Advanced Radiotherapy Center, European Institute of Oncology, Milano, Italy
References: Hodgson, D.C., Late effects in the era of modern therapy for Hodgkin lymphoma (2011) Hematology Am Soc Hematol Educ Program, 2011, pp. 323-329. , 10.1182/asheducation-2011.1.323, 2216005
Ng, A.K., Review of the cardiac long-term effects of therapy for Hodgkin lymphoma (2011) Br J Haematol, 154 (1), pp. 23-31. , 10.1111/j.1365-2141.2011.08713.x, 21539537
Elkin, E.B., Klem, M.L., Gonzales, A.M., Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study (2011) J Clin Oncol, 29 (18), pp. 2466-2473. , 10.1200/JCO.2010.32.4079, 3138631, 21576642
Hoppe, B.S., Flampouri, S., Lynch, J., Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy (2012) Oncology (Williston Park), 26 (5), pp. 456-459. , 462-455
Li, J., Dabaja, B., Reed, V., Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma (2011) Int J Radiat Oncol Biol Phys, 81 (1), pp. 167-174. , 10.1016/j.ijrobp.2010.05.007, 20643518
Lu, N.N., Li, Y.X., Wu, R.Y., Dosimetric and Clinical Outcomes of Involved-Field Intensity-Modulated Radiotherapy After Chemotherapy for Early-Stage Hodgkin's Lymphoma With Mediastinal Involvement (2012) Int J Radiat Oncol Biol Phys, 84 (1), pp. 210-216. , 10.1016/j.ijrobp.2011.11.008, 22436783
Vlachaki, M.T., Kumar, S., Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease - a feasibility study (2010) J Appl Clin Med Phys, 11 (1), p. 3042
Nieder, C., Schill, S., Kneschaurek, P., Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts (2007) Radiother Oncol, 82 (3), pp. 301-307. , 10.1016/j.radonc.2006.10.015, 17156873
Fiandra, C., Filippi, A.R., Catuzzo, P., Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations (2012) Radiat Oncol, 7 (1), p. 186. , 10.1186/1748-717X-7-186, 3502518, 23122028
De Sanctis, V., Bolzan, C., D'Arienzo, M., Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy? (2012) Radiat Oncol, 7, p. 129. , 10.1186/1748-717X-7-129, 3484070, 22857015
Fox, A.M., Dosoretz, A.P., Mauch, P.M., Predictive factors for radiation pneumonitis in hodgkin lymphoma patients receiving combined-modality therapy (2012) Int J Radiat Oncol Biol Phys, 83 (1), pp. 277-283. , 10.1016/j.ijrobp.2011.05.078, 22019238
Cella, L., Conson, M., Caterino, M., Thyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin's Lymphoma (2012) Int J Radiat Oncol Biol Phys, 82 (5), pp. 1802-1808. , 10.1016/j.ijrobp.2010.09.054, 21514076
Cella, L., Liuzzi, R., Conson, M., Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma (2011) Radiother Oncol, 101 (2), pp. 316-321. , 10.1016/j.radonc.2011.08.040, 21925755
Gagliardi, G., Constine, L.S., Moiseenko, V., Radiation dose-volume effects in the heart (2010) Int J Radiat Oncol Biol Phys, 76 (3 SUPPL), pp. S77-85
Hall, E.J., Wuu, C.S., Radiation-induced second cancers: the impact of 3D-CRT and IMRT (2003) Int J Radiat Oncol Biol Phys, 56 (1), pp. 83-88. , 10.1016/S0360-3016(03)00073-7, 12694826
Newhauser, W.D., Durante, M., Assessing the risk of second malignancies after modern radiotherapy (2011) Nat Rev Cancer, 11 (6), pp. 438-448. , 10.1038/nrc3069, 21593785
Berrington De Gonzalez, A., Gilbert, E., Curtis, R., Second Solid Cancers After Radiation Therapy: A Systematic Review of the Epidemiologic Studies of the Radiation Dose-response Relationship (2012) Int J Radiat Oncol Biol Phys, , Epub ahead of print
Schneider, U., Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula (2009) Med Phys, 36 (4), pp. 1138-1143. , 10.1118/1.3089792, 19472619
Schneider, U., Sumila, M., Robotka, J., Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy (2011) Theor Biol Med Model, 8, p. 27. , 10.1186/1742-4682-8-27, 3161945, 21791103
Shuryak, I., Hahnfeldt, P., Hlatky, L., A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach (2009) Radiat Environ Biophys, 48 (3), pp. 263-274. , 10.1007/s00411-009-0230-3, 2714893, 19536557
Feng, M., Moran, J.M., Koelling, T., Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer (2011) Int J Radiat Oncol Biol Phys, 79 (1), pp. 10-18. , 10.1016/j.ijrobp.2009.10.058, 2937165, 20421148
Weber, D.C., Peguret, N., Dipasquale, G., Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study (2009) Int J Radiat Oncol Biol Phys, 75 (5), pp. 1578-1586. , 10.1016/j.ijrobp.2009.05.012, 19596171
D'Errico, F., Luszik-Bhadra, M., Nath, R., Depth dose-equivalent and effective energies of photoneutrons generated by 6-18 MV X-ray beams for radiotherapy (2001) Health Phys, 80 (1), pp. 4-11. , 10.1097/00004032-200101000-00003, 11204115
Schneider, U., Agosteo, S., Pedroni, E., Secondary neutron dose during proton therapy using spot scanning (2002) Int J Radiat Oncol Biol Phys, 53 (1), pp. 244-251. , 10.1016/S0360-3016(01)02826-7, 12007965
Engert, A., Plutschow, A., Eich, H.T., Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma (2010) N Engl J Med, 363 (7), pp. 640-652. , 10.1056/NEJMoa1000067, 20818855
Campbell, B.A., Hornby, C., Cunninghame, J., Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy (2012) Ann Oncol, 23 (5), pp. 1259-1266. , 10.1093/annonc/mdr439, 21980193
(2003) Relative Biological Effectiveness, Radiation Weighting and Quality Factor". ICRP Publication 92. Ann. ICRP 33 (4), , ICRP
Edwards, A.A., Lloyd, D.C., Prosser, J.S., Chromosome aberrations induced in human lymphocytes by 8.7 MeV protons and 23.5 MeV helium-3 ions (1986) Int J Radiat Biol Relat Stud Phys Chem Med, 50 (1), pp. 137-145. , 10.1080/09553008614550511, 3013793
(1990) The relative biological effectiveness of radiations of different quality. NCRP Report 104, , NCRP
Foote, R.L., Stafford, S.L., Petersen, I.A., The clinical case for proton beam therapy (2012) Radiat Oncol, 7 (1), p. 174. , 10.1186/1748-717X-7-174, 3549771, 23083010
Schippers, J.M., Lomax, A.J., Emerging technologies in proton therapy (2011) Acta Oncol, 50 (6), pp. 838-850. , 10.3109/0284186X.2011.582513, 21767183
Hodgson, D. C., Late effects in the era of modern therapy for Hodgkin lymphoma (2011) Hematology Am Soc Hematol Educ Program, 2011, pp. 323-329. , 10. 1182/asheducation-2011. 1. 323, 2216005
Ng, A. K., Review of the cardiac long-term effects of therapy for Hodgkin lymphoma (2011) Br J Haematol, 154 (1), pp. 23-31. , 10. 1111/j. 1365-2141. 2011. 08713. x, 21539537
Elkin, E. B., Klem, M. L., Gonzales, A. M., Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study (2011) J Clin Oncol, 29 (18), pp. 2466-2473. , 10. 1200/JCO. 2010. 32. 4079, 3138631, 21576642
Hoppe, B. S., Flampouri, S., Lynch, J., Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy (2012) Oncology (Williston Park), 26 (5), pp. 456-459. , 462-455
Lu, N. N., Li, Y. X., Wu, R. Y., Dosimetric and Clinical Outcomes of Involved-Field Intensity-Modulated Radiotherapy After Chemotherapy for Early-Stage Hodgkin's Lymphoma With Mediastinal Involvement (2012) Int J Radiat Oncol Biol Phys, 84 (1), pp. 210-216. , 10. 1016/j. ijrobp. 2011. 11. 008, 22436783
Vlachaki, M. T., Kumar, S., Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease - a feasibility study (2010) J Appl Clin Med Phys, 11 (1), p. 3042
Fox, A. M., Dosoretz, A. P., Mauch, P. M., Predictive factors for radiation pneumonitis in hodgkin lymphoma patients receiving combined-modality therapy (2012) Int J Radiat Oncol Biol Phys, 83 (1), pp. 277-283. , 10. 1016/j. ijrobp. 2011. 05. 078, 22019238
Hall, E. J., Wuu, C. S., Radiation-induced second cancers: the impact of 3D-CRT and IMRT (2003) Int J Radiat Oncol Biol Phys, 56 (1), pp. 83-88. , 10. 1016/S0360-3016 (03) 00073-7, 12694826
Newhauser, W. D., Durante, M., Assessing the risk of second malignancies after modern radiotherapy (2011) Nat Rev Cancer, 11 (6), pp. 438-448. , 10. 1038/nrc3069, 21593785
Weber, D. C., Peguret, N., Dipasquale, G., Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study (2009) Int J Radiat Oncol Biol Phys, 75 (5), pp. 1578-1586. , 10. 1016/j. ijrobp. 2009. 05. 012, 19596171
Campbell, B. A., Hornby, C., Cunninghame, J., Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy (2012) Ann Oncol, 23 (5), pp. 1259-1266. , 10. 1093/annonc/mdr439, 21980193
(2003) Relative Biological Effectiveness, Radiation Weighting and Quality Factor". ICRP Publication 92. Ann. ICRP 33 (4), , ICRP
Edwards, A. A., Lloyd, D. C., Prosser, J. S., Chromosome aberrations induced in human lymphocytes by 8. 7 MeV protons and 23. 5 MeV helium-3 ions (1986) Int J Radiat Biol Relat Stud Phys Chem Med, 50 (1), pp. 137-145. , 10. 1080/09553008614550511, 3013793
(1990) The relative biological effectiveness of radiations of different quality. NCRP Report 104, , NCRP
Foote, R. L., Stafford, S. L., Petersen, I. A., The clinical case for proton beam therapy (2012) Radiat Oncol, 7 (1), p. 174. , 10. 1186/1748-717X-7-174, 3549771, 23083010
Schippers, J. M., Lomax, A. J., Emerging technologies in proton therapy (2011) Acta Oncol, 50 (6), pp. 838-850. , 10. 3109/0284186X. 2011. 582513, 21767183
Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms
Cusanno F, Cisbani E, Colilli S, Fratoni R, Garibaldi F, Giuliani F, Gricia M, Lucentini M, Magliozzi ML, Santarivenere F, Torrioli S, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, De Vincentis G, Scopinaro F * Results of clinical trials with SPEM(278 views) Nucl Instrum Methods Phys Res Sect A, 2007 Feb 1; 497(1): 46-50. Impact Factor:3.221 ViewExport to BibTeXExport to EndNote